Literature DB >> 21505150

Ornithine decarboxylase is upregulated by the androgen receptor in skeletal muscle and regulates myoblast proliferation.

Nicole K L Lee1, Jarrod P J Skinner, Jeffrey D Zajac, Helen E MacLean.   

Abstract

The aim of this study is to determine if the Odc1 gene, which encodes ornithine decarboxylase (ODC), the rate-limiting enzyme in polyamine biosynthesis, is directly regulated by the androgen receptor (AR) in skeletal muscle myoblasts and if Odc1 regulates myoblast proliferation and differentiation. We previously showed that expression of Odc1 is decreased in muscle from AR knockout male mice. In this study, we show in vivo that Odc1 expression is also decreased >60% in muscle from male muscle-specific AR knockout mice. In normal muscle homeostasis, Odc1 expression is regulated by age and sex, reflecting testosterone levels, as muscle of adult male mice expresses high levels of Odc1 compared with age-matched females and younger males. In vitro, expression of Odc1 is 10- and 1.5-fold higher in proliferating mouse C(2)C(12) and human skeletal muscle myoblasts, respectively, than in differentiated myotubes. Dihydrotestosterone increases Odc1 levels 2.7- and 1.6-fold in skeletal muscle cell myoblasts after 12 and 24 h of treatment, respectively. Inhibition of ODC activity in C(2)C(12) myoblasts by α-difluoromethylornithine decreases myoblast number by 40% and 66% following 48 and 72 h of treatment, respectively. In contrast, overexpression of Odc1 in C(2)C(12) myoblasts results in a 27% increase in cell number vs. control when cells are grown under differentiation conditions for 96 h. This prolonged proliferation is associated with delayed differentiation, with reduced expression of the differentiation markers myogenin and Myf6 in Odc1-overexpressing cells. In conclusion, androgens act via the AR to upregulate Odc1 in skeletal muscle myoblasts, and Odc1 promotes myoblast proliferation and delays differentiation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21505150     DOI: 10.1152/ajpendo.00094.2011

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  16 in total

Review 1.  Androgens and skeletal muscle: cellular and molecular action mechanisms underlying the anabolic actions.

Authors:  Vanessa Dubois; Michaël Laurent; Steven Boonen; Dirk Vanderschueren; Frank Claessens
Journal:  Cell Mol Life Sci       Date:  2011-11-19       Impact factor: 9.261

2.  Polyamines transduce the nongenomic, androgen-induced calcium sensitization in intestinal smooth muscle.

Authors:  María C González-Montelongo; Raquel Marín; José A Pérez; Tomás Gómez; Mario Díaz
Journal:  Mol Endocrinol       Date:  2013-09-03

3.  Ornithine Decarboxylase Is Sufficient for Prostate Tumorigenesis via Androgen Receptor Signaling.

Authors:  Amita Shukla-Dave; Mireia Castillo-Martin; Ming Chen; Jose Lobo; Nataliya Gladoun; Ana Collazo-Lorduy; Faisal M Khan; Vladimir Ponomarev; Zhengzi Yi; Weijia Zhang; Pier P Pandolfi; Hedvig Hricak; Carlos Cordon-Cardo
Journal:  Am J Pathol       Date:  2016-10-19       Impact factor: 4.307

4.  The effects of testosterone deprivation and supplementation on proteasomal and autophagy activity in the skeletal muscle of the male mouse: differential effects on high-androgen responder and low-androgen responder muscle groups.

Authors:  Carlo Serra; Nicolae Lucian Sandor; Hyeran Jang; Daniel Lee; Gianluca Toraldo; Tyler Guarneri; Siu Wong; Anqi Zhang; Wen Guo; Ravi Jasuja; Shalender Bhasin
Journal:  Endocrinology       Date:  2013-10-08       Impact factor: 4.736

5.  Plasma Biomarkers of Poor Muscle Quality in Older Men and Women from the Baltimore Longitudinal Study of Aging.

Authors:  Ruin Moaddel; Elisa Fabbri; Mohammed A Khadeer; Olga D Carlson; Marta Gonzalez-Freire; Pingbo Zhang; Richard D Semba; Luigi Ferrucci
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-03-30       Impact factor: 6.053

6.  Blockade of Metallothioneins 1 and 2 Increases Skeletal Muscle Mass and Strength.

Authors:  Serge Summermatter; Anais Bouzan; Eliane Pierrel; Stefan Melly; Daniela Stauffer; Sabine Gutzwiller; Erin Nolin; Christina Dornelas; Christy Fryer; Juliet Leighton-Davies; David J Glass; Brigitte Fournier
Journal:  Mol Cell Biol       Date:  2017-02-15       Impact factor: 4.272

7.  Sex-related differences in urinary immune-related metabolic profiling of alopecia areata patients.

Authors:  Yu Ra Lee; Haksoon Kim; Bark Lynn Lew; Woo Young Sim; Jeongae Lee; Han Bin Oh; Jongki Hong; Bong Chul Chung
Journal:  Metabolomics       Date:  2020-01-16       Impact factor: 4.290

8.  Neuronal androgen receptor is required for activity dependent enhancement of peripheral nerve regeneration.

Authors:  Patricia J Ward; Rachel A Davey; Jeffrey D Zajac; Arthur W English
Journal:  Dev Neurobiol       Date:  2021-05-02       Impact factor: 3.102

9.  Characterization of GLPG0492, a selective androgen receptor modulator, in a mouse model of hindlimb immobilization.

Authors:  Roland Blanqué; Liên Lepescheux; Marielle Auberval; Dominique Minet; Didier Merciris; Céline Cottereaux; Philippe Clément-Lacroix; Philippe Delerive; Florence Namour
Journal:  BMC Musculoskelet Disord       Date:  2014-09-03       Impact factor: 2.362

10.  Combined administration of testosterone plus an ornithine decarboxylase inhibitor as a selective prostate-sparing anabolic therapy.

Authors:  Ravi Jasuja; James C Costello; Rajan Singh; Vandana Gupta; Catherine S Spina; Gianluca Toraldo; Hyeran Jang; Hu Li; Carlo Serra; Wen Guo; Pratibha Chauhan; Navjot S Narula; Tyler Guarneri; Ayla Ergun; Thomas G Travison; James J Collins; Shalender Bhasin
Journal:  Aging Cell       Date:  2013-12-04       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.